Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2019-11-30 |
2010-12 |
0 |
N/A |
N/A |
N/A |
2016-11-10 |
2016-09 |
0 |
0.02 |
N/A |
N/A |
2016-08-22 |
2016-06 |
0 |
-0.01 |
N/A |
N/A |
2016-05-19 |
2016-03 |
0 |
-0.01 |
N/A |
N/A |
2016-03-31 |
2015-12 |
0 |
-0.04 |
N/A |
N/A |
2015-11-17 |
2015-09 |
0 |
-0.01 |
N/A |
N/A |
Date |
Firm |
Action |
From |
To |
2023-10-15 |
RBC Capital |
Upgrade |
|
Outperform |
2023-04-27 |
HC Wainwright & Co. |
Upgrade |
|
Buy |
2023-04-11 |
HC Wainwright & Co. |
Upgrade |
|
Buy |
2023-03-27 |
Ladenburg Thalmann |
Upgrade |
|
Buy |
2023-03-13 |
HC Wainwright & Co. |
Upgrade |
|
Buy |
2023-01-05 |
Piper Sandler |
Upgrade |
Neutral |
Overweight |
Date |
Name |
Relation |
Quantity |
Description |
2023-06-14 |
CRESS MICHAEL D |
Director |
22.17K |
Stock Award(Grant) |
2023-06-14 |
DISBROW JOSHUA R. |
Director |
22.17K |
Stock Award(Grant) |
2024-04-29 |
LUCSOK ANNA |
Chief Operating Officer |
113.72K |
Stock Award(Grant) |
2023-06-14 |
MICHAELS BARRY D |
Director |
22.17K |
Stock Award(Grant) |
2024-03-04 |
MOORHEAD DANIEL J |
Chief Financial Officer |
80.64K |
Stock Award(Grant) |
2021-04-13 |
PAPANDREA GIUSEPPE |
Officer |
31.06K |
Conversion of Exercise of derivative security |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Blackrock Inc. |
3.24M |
31.10M |
10.06% |
2023-06-29 |
Vanguard Group Inc |
1.54M |
14.80M |
4.79% |
2023-06-29 |
State Street Corporation |
710.16K |
6.81M |
2.20% |
2023-06-29 |
Millennium Management Llc |
445.66K |
4.27M |
1.38% |
2023-06-29 |
Geode Capital Management, LLC |
433.19K |
4.15M |
1.34% |
2023-06-29 |
Morgan Stanley |
382.99K |
3.67M |
1.19% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Total Stock Market Index Fund |
732.91K |
7.03M |
2.27% |
2023-08-30 |
iShares Russell 2000 ETF |
442.09K |
3.40M |
1.37% |
2023-06-29 |
Vanguard Extended Market Index Fund |
306.08K |
2.94M |
0.95% |
2023-06-29 |
Vanguard Tax Managed Fund-Small Cap Fund |
196.71K |
1.89M |
0.61% |
2023-07-30 |
Fidelity Small Cap Index Fund |
174.06K |
1.70M |
0.54% |
2023-08-30 |
SPDR Portfolio S&P 600 Small Cap ETF |
169.08K |
1.30M |
0.52% |
Dividend |
Date |
0.1 |
2022-01-05 |
0.07 |
2018-12-31 |
0.15 |
2014-06-17 |
Split |
Date |
110 : 100 |
2022-01-05 |